1 Center for Clinical Microbiology, Division of Infection and Immunity, University College London and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UK. Electronic address: a.i.zumla@gmail.com.
2 Critical Path to TB Drug Regimens, Critical Path Institute, Tucson, AZ, USA.
3 Kenya Medical Research Institute, Nairobi, Kenya.
4 The Children's Hospital at Westmead, Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
5 Ministry of Health, Lusaka, Zambia.
6 WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S Maugeri, Care and Research Institute, Tradate, Italy.
7 Division of Infectious Diseases and Tropical Medicine, Medical Centre of the University of Munich, and DZIF German Centre for Infection Research, Munich, Germany.
8 Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institutet, and Centre for Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Stockholm, Sweden.